Discover 1,416 paid clinical trials in Sarasota, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,416
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
for
Respiratory Syncytial Virus Immunization,
Location: Largo FL, Lakeland FL, Maitland FL, DeLand FL,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07734649
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: St. Petersburg FL, Orange City FL, Gainesville FL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase 3, Recruiting
Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)
for
Obstructive Sleep Apnea
Location: St. Petersburg FL, Dallas TX
Sponsor: ApniCure, Inc.
Sex: All
Age: 18+
Code: NCT01683721
Recruiting
Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study
for
Tinea Unguium, Onychomycosis
Location: Saint Petersburg FL
Sponsor: William N Handelman
Sex: All
Age: 21 - 70+
Code: NCT04341402
Phase 2, Recruiting
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
for
Atopic Dermatitis
Location: Saint Petersburg FL, Orange City FL,
Sponsor: ASLAN Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05694884
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy
Location: St. Petersburg FL, Gainesville FL, Stuart FL, Ladson SC,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07215234
Phase 1, Phase 2, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Tampa FL, Winter Park FL, Gainesville FL, Hollywood FL,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: St. Petersburg FL, Durham NC, Nashville TN, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase 2, Recruiting
PEN-866 in Patients With Advanced Solid Malignancies
for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Saint Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Tarveda Therapeutics
Sex: All
Age: 18+
Code: NCT03221400
Phase 1, Phase 2, Recruiting
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
for
Drug; Withdrawal Symptoms, Neonatal, Withdrawal,
Location: St Petersburg FL
Sponsor: Gauda, Estelle B., M.D.
Sex: All
Age: 0
Code: NCT02249026
Phase 1, Phase 2, Recruiting
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
for
Moderate-to-Severe Atopic Dermatitis
Location: St. Petersburg FL, Tampa FL, Boca Raton FL, Macon GA,
Sponsor: Nektar Therapeutics
Sex: All
Age: 12+
Code: NCT07690371
Phase 3, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Location: St. Petersburg FL, Tampa FL, Lakeland FL, Fort Myers FL,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase 3, Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Bradenton FL, Viera FL, Ocala FL, Jupiter FL,
Sponsor: Eccogene
Sex: All
Age: 18 - 70+
Code: NCT07288138
Phase 2, Recruiting
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
for
Non Alcoholic Steatohepatitis (NASH)
Location: Bradenton FL, Pinellas Park FL, Clearwater FL, Ocoee FL,
Sponsor: Axcella Health, Inc
Sex: All
Age: 18+
Code: NCT04880187
Phase 2, Recruiting
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
for
Breast Cancer, Metastatic
Location: Tampa FL, Miami FL, Jacksonville FL, Durham NC,
Sponsor: ALX Oncology Inc.
Sex: All
Age: 18+
Code: NCT07007559
Phase 2, Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Bradenton FL, Orlando FL, Homewood AL, New Orleans LA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase 3, Recruiting
Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis
Location: Lakewood Rch FL, Miami FL, Morehead City NC,
Sponsor: Madrigal Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07848191
Phase 4, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
for
Heart Failure
Location: Bradenton FL, Miramar FL, Fort Lauderdale FL,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06024746
Phase 3, Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists